Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Abbvie (ABBV)

AbbVie Presents New Data Across Its Blood Cancer Portfolio At EHA 2026 6/8/2026 8:06:01 AM

Weekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart 5/29/2026 10:39:40 AM

AbbVie's VENCLYXTO Label Gets EU Approval For Chronic Lymphocytic Leukemia Treatment 5/29/2026 8:56:58 AM

AbbVie Gains EU Approval For Expanded VENCLYXTO® Label In Untreated Chronic Lymphocytic Leukemia 5/29/2026 8:02:02 AM

FDA Greenlights AbbVie's DECNUPAZ For BPDCN, A Rare Blood Cancer 5/28/2026 2:01:45 AM

FDA Approves AbbVie's DECNUPAZ For Adult BPDCN, Ultra-Rare Aggressive Blood Cancer 5/27/2026 10:53:34 PM

AbbVie's MAVIRET Secures Positive CHMP Opinion For Acute Hepatitis C Infection Treatment 5/22/2026 8:38:02 AM

AbbVie Gains CHMP Positive Opinion For MAVIRET In Acute Hepatitis C Treatment 5/22/2026 8:01:47 AM

AbbVie Presents Long-Term IBD Data At DDW 2026, Reinforces SKYRIZI And RINVOQ Efficacy And Durability 5/5/2026 8:24:07 AM

AbbVie's SKYRIZI Secures Listing On Ontario And Alberta Formularies For UC Treatment 5/4/2026 8:09:06 AM

AbbVie: SKYRIZI Secures Listing On Ontario And Alberta Formularies In Ulcerative Colitis 5/4/2026 7:06:57 AM

AbbVie Q1 Profit Down, Revenues Rise; Lifts FY26 Earnings View - Update 4/29/2026 8:30:03 AM

AbbVie Q1 26 Earnings Conference Call At 9:00 AM ET 4/29/2026 8:01:15 AM

AbbVie Q1 Profit Drops 4/29/2026 7:52:01 AM

AbbVie Q1 EPS $0.39, Decrease Of 45.8%; Raises 2026 Adj. EPS Guidance 4/29/2026 7:49:23 AM

AbbVie Seeks FDA Approval To Expand RINVOQ Use For Alopecia Areata 4/29/2026 3:21:04 AM

AbbVie Submits FDA Application For RINVOQ In Severe Alopecia Areata Based On Phase 3 Data 4/28/2026 8:13:26 AM

AbbVie Says Rinvoq Tops Humira In Rheumatoid Arthritis Study 4/28/2026 7:35:05 AM

AbbVie : RINVOQ Outperforms HUMIRA In Head-to-Head Rheumatoid Arthritis Study 4/28/2026 7:04:05 AM

AbbVie Seeks FDA Nod For SKYRIZI Subcutaneous Induction In Crohn's Disease 4/27/2026 8:32:06 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap